Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jingyuan Liu and Zhihai Chen.
Jingyuan Liu
Connection Strength
1.077
Zhihai Chen
  1. Comparative therapeutic efficacy of interferon alfa-2b and combination lopinavir/ritonavir plus interferon alfa-2b against SARS-CoV-2. BMC Infect Dis. 2021 Aug 30; 21(1):885.
    View in: PubMed
    Score: 0.241
  2. Yindan Jiedu Granules, a Traditional Chinese Medicinal Formulation, as a Potential Treatment for Coronavirus Disease 2019. Front Pharmacol. 2020; 11:634266.
    View in: PubMed
    Score: 0.232
  3. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020 05 20; 18(1):206.
    View in: PubMed
    Score: 0.221
  4. The first imported case of Rift Valley fever in China reveals a genetic reassortment of different viral lineages. Emerg Microbes Infect. 2017 Jan 18; 6(1):e4.
    View in: PubMed
    Score: 0.175
  5. Genomic surveillance of COVID-19 cases in Beijing. Nat Commun. 2020 10 30; 11(1):5503.
    View in: PubMed
    Score: 0.057
  6. Differentiating Between 2019 Novel Coronavirus Pneumonia and Influenza Using a Nonspecific Laboratory Marker-Based Dynamic Nomogram. Open Forum Infect Dis. 2020 May; 7(5):ofaa169.
    View in: PubMed
    Score: 0.055
  7. Phylogenomic analysis unravels evolution of yellow fever virus within hosts. PLoS Negl Trop Dis. 2018 09; 12(9):e0006738.
    View in: PubMed
    Score: 0.049
  8. High Level of Neutrophil Extracellular Traps Correlates With Poor Prognosis of Severe Influenza A Infection. J Infect Dis. 2018 01 17; 217(3):428-437.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.